CTLA4 and neoplasm: CDNs increased the infiltration of tumor‐specific cytotoxic T‐cells and enhanced the therapeutic efficacy of anti‐PD‐1 and anti‐CTLA‐4, reprogramming immunosuppressive, M2‐polarized tumor‐associated macrophages to a pro‐inflammatory M1‐macrophages.34